Download
s12883-020-01966-z.pdf 1,12MB
WeightNameValue
1000 Titel
  • Ex vivo radiosensitivity is increased in non-cancer patients taking valproate
1000 Autor/in
  1. Stritzelberger, Jenny |
  2. Lainer, Jennifer |
  3. Gollwitzer, Stefanie |
  4. Graf, Wolfgang |
  5. Jost, Tina |
  6. Lang, Johannes D. |
  7. Mueller, Tamara M. |
  8. Schwab, Stefan |
  9. Fietkau, Rainer |
  10. Hamer, Hajo M. |
  11. Distel, Luitpold |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-10-24
1000 Erschienen in
1000 Quellenangabe
  • 20(1):390
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1186/s12883-020-01966-z |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7585294/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Valproate (VPA) is a commonly prescribed antiepileptic drug for patients experiencing epileptic seizures due to brain tumors. VPA increases radiation sensitivity in various tumor cells in vitro due to complex mechanisms. This could make tumors more vulnerable to ionizing radiation or overcome radioresistance. Yet, clinical data on possible improvement of tumor control by adding VPA to tumor therapy is controversial. Potentially radiosensitizing effects of VPA on healthy tissue remain unclear. To determine individual radiosensitivity, we analyzed blood samples of individuals taking VPA.!##!Methods!#!Ex vivo irradiated blood samples of 31 adult individuals with epilepsy were studied using 3-color fluorescence in situ hybridization. Aberrations in chromosomes 1, 2 and 4 were analyzed. Radiosensitivity was determined by the mean breaks per metaphase (B/M) and compared to age-matched (2:1) healthy donors.!##!Results!#!The patient cohort (n = 31; female: 38.7%) showed an increase of their average B/M value compared to healthy individuals (n = 61; female: 56.9%; B/M: 0.480 ± 0.09 vs. 0.415 ± 0.07; p = .001). The portion of radiosensitive (B/M >  0.500) and distinctly radiosensitive individuals (B/M >  0.600) was increased in the VPA group (54.9% vs. 11.3 and 9.7% vs. 0.0%; p < .001). In 3/31 patients, radiosensitivity was determined prior to and after VPA treatment and radiosensitivity was increased by VPA-treatment.!##!Conclusions!#!In our study, we confirmed that patients treated with VPA had an increased radiosensitivity compared to the control group. This could be considered in patients taking VPA prior to the beginning of radiotherapy to avoid toxic side effects of VPA-treatment.
1000 Sacherschließung
lokal Anticonvulsants/pharmacology [MeSH]
lokal Female [MeSH]
lokal Aged, 80 and over [MeSH]
lokal Aged [MeSH]
lokal Individual radiosensitivity
lokal Valproate
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Epilepsy/drug therapy [MeSH]
lokal Radiation-Sensitizing Agents/pharmacology [MeSH]
lokal 3-colour fluorescence-in-situ-hybridization
lokal Middle Aged [MeSH]
lokal Valproic Acid/pharmacology [MeSH]
lokal Cohort Studies [MeSH]
lokal Breaks per metaphase
lokal Lymphocytes/drug effects [MeSH]
lokal Lymphocytes/radiation effects [MeSH]
lokal Male [MeSH]
lokal Radiation Tolerance [MeSH]
lokal Young Adult [MeSH]
lokal Cells, Cultured [MeSH]
lokal Research Article
lokal Epilepsy
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-4888-6539|https://frl.publisso.de/adhoc/uri/TGFpbmVyLCBKZW5uaWZlcg==|https://frl.publisso.de/adhoc/uri/R29sbHdpdHplciwgU3RlZmFuaWU=|https://frl.publisso.de/adhoc/uri/R3JhZiwgV29sZmdhbmc=|https://frl.publisso.de/adhoc/uri/Sm9zdCwgVGluYQ==|https://frl.publisso.de/adhoc/uri/TGFuZywgSm9oYW5uZXMgRC4=|https://frl.publisso.de/adhoc/uri/TXVlbGxlciwgVGFtYXJhIE0u|https://frl.publisso.de/adhoc/uri/U2Nod2FiLCBTdGVmYW4=|https://frl.publisso.de/adhoc/uri/RmlldGthdSwgUmFpbmVy|https://frl.publisso.de/adhoc/uri/SGFtZXIsIEhham8gTS4=|https://frl.publisso.de/adhoc/uri/RGlzdGVsLCBMdWl0cG9sZA==
1000 Hinweis
  • DeepGreen-ID: 35a4de63886f464bb70b733281670732 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6464587.rdf
1000 Erstellt am 2023-11-16T05:23:12.648+0100
1000 Erstellt von 322
1000 beschreibt frl:6464587
1000 Zuletzt bearbeitet 2023-12-01T00:19:40.852+0100
1000 Objekt bearb. Fri Dec 01 00:19:40 CET 2023
1000 Vgl. frl:6464587
1000 Oai Id
  1. oai:frl.publisso.de:frl:6464587 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source